Farmington Hills, Michigan, December 4, 2024— LSPedia, a leading provider of traceability and compliance solutions for the pharmaceutical industry, today announced a strategic partnership with Omnicell, Inc.(Nasdaq: OMCL), a leader in transforming the pharmacy care delivery model. This collaboration aims to streamline pharmaceutical supply chain operations and strengthen compliance with regulatory standards such as the Drug Supply Chain Security Act(DSCSA).
LSPedia and Omnicell have already joined forces to support Kentucky-based Baptist Health and other health systems in their efforts to achieve compliance and improve supply chain transparency. By formalizing this partnership, the companies aim to expand their reach and enhance their combined offerings to healthcare providers, pharmaceutical manufacturers, and distributors across the U.S.
The partnership integrates LSPedia’s OneScan® traceability and compliance platform with Omnicell’s comprehensive portfolio of robotics, smart devices, and intelligent software. Together, the companies will offer solutions that empower healthcare providers to achieve end-to-end visibility and control in the supply chain, while reducing costs and mitigating risks associated with counterfeit drugs.
“This collaboration with Omnicell represents a powerful alignment of expertise and technology,” said Daniel MacKinnon, Senior Vice President of Sales and Marketing at LSPedia. “We’re thrilled to be working together to drive innovation and efficiency for organizations like Baptist Health and other forward-thinking health systems. Our shared goal is to provide transformative solutions that ensure compliance, enhance operational efficiency, and protect patients.”
Omnicell has been at the forefront of transforming pharmacy care since 1992, leveraging cutting-edge technology to enhance clinical and business outcomes. By partnering with LSPedia, Omnicell can further strengthen its commitment to the Autonomous Pharmacy vision, empowering healthcare providers to focus more on patient care and less on administrative burdens.
“Our partnership with LSPedia underscores our dedication to providing innovative solutions that address the unique challenges of the pharmaceutical supply chain,” said [Omnicell Executive Name &Title]. “By combining our expertise, we can deliver transformative solutions that optimize compliance and drive meaningful outcomes for our customers.”
The integration of LSPedia and Omnicell’s technologies offers customers:
This partnership represents a significant step forward in achieving a more resilient, transparent, and efficient pharmaceutical supply chain.
ABOUT OMNICELL
Since 1992, Omnicell has been committed to transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care. Through a comprehensive portfolio of robotics, smart devices, intelligent software, and expert services, Omnicell solutions are helping healthcare facilities worldwide to reduce costs, improve labor efficiency, establish new revenue streams, enhance supply chain control, support compliance, and move closer to the industry vision of the Autonomous Pharmacy. To learn more, visit www.omnicell.com.
ABOUT LSPedia® –Empowering Supply Chain
LSPedia is a global leader in SaaS solutions for compliance, serialization, and traceability in the pharmaceutical industry. Our OneScan® and Investigator™ platforms streamline supply chain operations and provide end-to-end visibility to ensure regulatory compliance and operational efficiency.
Traceability protects your business and fosters improved decision-making. Contact LSPedia at (855) ONE-SCAN (663-7226), email trace@lspedia.com, or visit www.lspedia.com.
.svg){kind=icon}
